FR2444060A1 - Complexes d'inclusion d'allycine avec les cyclodextrines, leur preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Complexes d'inclusion d'allycine avec les cyclodextrines, leur preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
FR2444060A1
FR2444060A1 FR7930212A FR7930212A FR2444060A1 FR 2444060 A1 FR2444060 A1 FR 2444060A1 FR 7930212 A FR7930212 A FR 7930212A FR 7930212 A FR7930212 A FR 7930212A FR 2444060 A1 FR2444060 A1 FR 2444060A1
Authority
FR
France
Prior art keywords
allycin
cyclodextrins
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7930212A
Other languages
English (en)
Other versions
FR2444060B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of FR2444060A1 publication Critical patent/FR2444060A1/fr
Application granted granted Critical
Publication of FR2444060B1 publication Critical patent/FR2444060B1/fr
Granted legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne les complexes d'inclusion d'allycine avec une cyclodextrine qui sont utiles comme médicaments.
FR7930212A 1978-12-12 1979-12-10 Complexes d'inclusion d'allycine avec les cyclodextrines, leur preparation et les compositions pharmaceutiques qui les contiennent Granted FR2444060A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78CI1871A HU177081B (en) 1978-12-12 1978-12-12 Process for preparing the occlusion complex of allicin with cyclodextrin

Publications (2)

Publication Number Publication Date
FR2444060A1 true FR2444060A1 (fr) 1980-07-11
FR2444060B1 FR2444060B1 (fr) 1984-06-29

Family

ID=10994715

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7930212A Granted FR2444060A1 (fr) 1978-12-12 1979-12-10 Complexes d'inclusion d'allycine avec les cyclodextrines, leur preparation et les compositions pharmaceutiques qui les contiennent

Country Status (11)

Country Link
JP (1) JPS55115866A (fr)
AT (1) AT363492B (fr)
CH (1) CH642347A5 (fr)
DE (1) DE2948869A1 (fr)
DK (1) DK526779A (fr)
FR (1) FR2444060A1 (fr)
GB (1) GB2061987B (fr)
HU (1) HU177081B (fr)
NO (1) NO794044L (fr)
SU (1) SU938732A3 (fr)
YU (1) YU299079A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550193A1 (fr) * 1983-08-05 1985-02-08 Sal Fine Chemicals Internation Complexes d'inclusion de trisulfure de methyle et d'allyle avec des cyclodextrines, leur procede de preparation et compositions pharmaceutiques les contenant
EP0147851A2 (fr) * 1983-12-29 1985-07-10 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Formes hydrosolubles d'antibiotiques du type polyène et procédé de leur préparation
EP0211392A2 (fr) * 1985-08-06 1987-02-25 Kao Corporation Shampooing liquide
EP0392608A2 (fr) * 1989-04-12 1990-10-17 The Procter & Gamble Company Produit solide d'utilisateur contenant des complexes de cyclodextrines sous forme de particules fines
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184066B (en) 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
DE3638290A1 (de) * 1986-11-07 1988-05-19 Herbe Wirkstoffe Gmbh Arzneimittelzubereitung
US4774329A (en) * 1987-08-04 1988-09-27 American Maize-Products Company Controlled release agent for cetylpyridinium chloride
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
CA2013485C (fr) * 1990-03-06 1997-04-22 John Michael Gardlik Produit solide contenant de petites particules de complexes de cyclodextrine
DE4024155C2 (de) * 1990-07-30 1995-12-07 Marcela Dipl Ing Holzhey Verwendung eines "Allicin-Urotropin" Produktes für den Bereich der inneren Behandlung (oral, Injektionen und Dauertropfinfusionen) von Menschen und Tieren bei Pilzerkrankungen
DE19500863A1 (de) * 1995-01-13 1996-07-18 Consortium Elektrochem Ind Verfahren zur Herstellung von Ajoen
GB0120887D0 (en) * 2001-08-29 2001-10-17 Sahajanand Biotech Private Ltd Local drug delivery system in coronary stents
GB0122793D0 (en) * 2001-09-21 2001-11-14 Stone Island Holdings Ltd Allicin
WO2005089571A1 (fr) * 2004-03-03 2005-09-29 Mousala, S., L. Utilisation d'extraits et de composes de plantes du genre allium comme agents conservateurs dans l'industrie alimentaire et agroalimentaire
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
CN107802842B (zh) * 2016-09-07 2022-04-12 汤臣倍健股份有限公司 大蒜素矫味制剂及其制备方法
CN107789345B (zh) * 2016-09-07 2022-06-28 汤臣倍健股份有限公司 矫味大蒜素-环糊精复合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174699B (hu) * 1977-07-01 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija natural'nykh i sinteticheskikh ciklodektrinnykh okkluzionnykh kompleksov prjaznostej, aromatov i vkusnykh vehhestv

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550193A1 (fr) * 1983-08-05 1985-02-08 Sal Fine Chemicals Internation Complexes d'inclusion de trisulfure de methyle et d'allyle avec des cyclodextrines, leur procede de preparation et compositions pharmaceutiques les contenant
EP0147851A2 (fr) * 1983-12-29 1985-07-10 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Formes hydrosolubles d'antibiotiques du type polyène et procédé de leur préparation
EP0147851A3 (en) * 1983-12-29 1986-12-30 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Water soluble forms of polyene antibiotics, and process for preparing them
EP0211392A2 (fr) * 1985-08-06 1987-02-25 Kao Corporation Shampooing liquide
EP0211392A3 (en) * 1985-08-06 1987-09-16 Kao Corporation Liquid shampoo composition
EP0392608A2 (fr) * 1989-04-12 1990-10-17 The Procter & Gamble Company Produit solide d'utilisateur contenant des complexes de cyclodextrines sous forme de particules fines
EP0392608A3 (fr) * 1989-04-12 1991-04-03 The Procter & Gamble Company Produit solide d'utilisateur contenant des complexes de cyclodextrines sous forme de particules fines
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten

Also Published As

Publication number Publication date
SU938732A3 (ru) 1982-06-23
AT363492B (de) 1981-08-10
HU177081B (en) 1981-07-28
ATA782979A (de) 1981-01-15
JPS55115866A (en) 1980-09-06
CH642347A5 (de) 1984-04-13
DE2948869A1 (de) 1980-07-03
GB2061987A (en) 1981-05-20
DE2948869C2 (fr) 1992-07-09
DK526779A (da) 1980-06-13
YU299079A (en) 1983-06-30
NO794044L (no) 1980-06-13
GB2061987B (en) 1983-05-18
JPS642105B2 (fr) 1989-01-13
FR2444060B1 (fr) 1984-06-29

Similar Documents

Publication Publication Date Title
FR2444060A1 (fr) Complexes d'inclusion d'allycine avec les cyclodextrines, leur preparation et les compositions pharmaceutiques qui les contiennent
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
IT1206608B (it) Ammidi derivate daltrimetossi-3,4,5-benzene e loro applicazione come prodotti medicinali.
IL56309A (en) Inclusion complex of cyclodextrin and indomethacin,its preparation and pharmaceutical compositions containing them
FR2391183A1 (fr) Hydroxyalkylphenones et leur application comme photosensibilisateurs
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
BE883415A (fr) Nouvelles thiovinyl-3 cephalosporines, leur preparation et les compositions qui les contiennent
IL58782A0 (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
IT1115787B (it) Perfezionamento nei preparari ant-acidita' in forma di compresse
FR2422624A1 (fr) Nouveaux agents anticholinergiques doues d'activite antisecretoire, leur procede de preparation et leurs utilisations
FR2369351A1 (fr) Particules d'
FR2422658A1 (fr) Composes piperazinyl-benzoheterocycliques, leur preparation et leurs utilisations therapeutiques
IT8447964A1 (it) Complessi d'inclusione, loro preparazione e loro impiego come insetticidi.
ES483662A1 (es) Un procedimiento para la produccion de una 2-aminoetil-1-fe-nilindolina
BE870646A (fr) Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments
LU81182A1 (fr) Nouveaux derives de l'isoquinoleine,leur preparation et les compositions pharmaceutiques qui les contiennent
FR2439787A1 (fr) Nouvelles cephalosporines, leur preparation et leurs applications therapeutiques
FR2358448A1 (fr) Nouveaux complexes cobaltiferes 1 : 2, leur preparation et leur application comme colorants
FR2422404A1 (fr) Compositions pharmaceutiques a base de 2,4-diamino-5-benzylpyrimidine et d'un sulfamide; et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse